X4 Pharmaceuticals (XFOR) Gains from Investment Securities (2017 - 2024)
X4 Pharmaceuticals' (XFOR) quarterly Gains from Investment Securities came in at $1.9 million in Q3 2024, up 107.41% YoY from $898714.3 in Q4 2023, and up 109.22% on a QoQ basis from -$20.2 million in Q2 2024.
X4 Pharmaceuticals (XFOR) Gains from Investment Securities (2017 - 2024) Analysis & Trends
X4 Pharmaceuticals (XFOR) has 3 years of Gains from Investment Securities data on file, last reported at $1.9 million in Q3 2024.
- Quarterly Gains from Investment Securities rose 107.41% year-over-year to $1.9 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$29.8 million (down 3905.38% YoY) and the FY2017 annual result came in at $31000.0, up 179.49% from the prior year.
- Gains from Investment Securities climbed to $1.9 million in Q3 2024, from -$20.2 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $29.9 million in Q2 2023 to a low of -$25.2 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | -20.22 Mn |
| Jun 30, 2024 | -20.22 Mn |
| Mar 31, 2024 | 13.76 Mn |
| Mar 31, 2024 | 13.76 Mn |
| Sep 30, 2023 | -25.16 Mn |
| Sep 30, 2023 | -25.16 Mn |
| Jun 30, 2023 | 29.86 Mn |
| Jun 30, 2023 | 29.86 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Dec 31, 2017 | 47,000.00 |
| Dec 31, 2017 | 47,000.00 |
| Sep 30, 2017 | -5,000.00 |
| Sep 30, 2017 | -5,000.00 |
| Jun 30, 2017 | -11,000.00 |
| Jun 30, 2017 | -11,000.00 |